Quarantine‑Associated Sleep Disorder (QASD)

Overview

Quarantine‑Associated Sleep Disorder (QASD) is a collective term for the range of sleep disturbances that emerged or worsened during periods of mandatory or self‑imposed isolation, such as those experienced during the COVID‑19 pandemic. It is not a separate clinical entity in the Diagnostic and Statistical Manual of Mental Disorders (DSM‑5) but rather a pattern of insomnia, hypersomnia, circadian‑rhythm disruption, and related symptoms linked to the psychosocial stresses of quarantine.

• Who it affects: Adults and adolescents of any age, with higher incidence in health‑care workers, students, and individuals living alone.
• Prevalence: A systematic review of 42 studies covering 2020‑2022 found that 35%–70% of respondents reported new or worsened sleep problems during lockdowns.^[1][2] In the United States, the CDC reported a 40% increase in insomnia symptoms compared with pre‑pandemic levels.^[3]

Symptoms

Symptoms can be acute (lasting weeks) or become chronic if unaddressed. The following list includes the most frequently reported manifestations:

• Difficulty falling asleep (sleep onset latency >30 min): Often coupled with racing thoughts about health, finances, or news.
• Frequent nocturnal awakenings: Waking up three or more times per night and having trouble returning to sleep.
• Early morning awakening: Waking up before the desired time and being unable to fall back asleep.
• Non‑restorative sleep: Feeling unrefreshed despite sleeping the “right” number of hours.
• Daytime sleepiness or hypersomnia: Excessive daytime fatigue, falling asleep in inappropriate settings.
• Shifted circadian rhythm: Delayed sleep phase (staying up very late, waking late) or advanced phase (early bedtime and wake time).
• Heightened arousal: Hypervigilance, irritability, or anxiety that interferes with sleep onset.
• Physical symptoms: Headaches, muscle tension, gastrointestinal upset that worsen at night.
• Behavioral changes: Increased screen time, irregular meals, reduced physical activity.

Causes and Risk Factors

QASD is multifactorial, arising from an interplay of environmental, psychological, and physiological triggers.

Primary Causes

• Psychological stress: Fear of infection, job insecurity, grief, and social isolation elevate cortisol and disrupt sleep architecture.^[4]
• Altered daily routine: Loss of structured work or school schedules leads to irregular sleep‑wake times.
• Increased screen exposure: Blue‑light from smartphones, tablets, and laptops suppresses melatonin production.
• Reduced physical activity: Sedentary behavior diminishes the homeostatic sleep drive.
• Substance use: Higher consumption of caffeine, alcohol, or nicotine during lockdowns can impair sleep.
• Environmental factors: Noise, cramped living spaces, and inadequate daylight exposure.

Risk Factors

• Pre‑existing sleep disorders (insomnia, sleep apnea).
• History of anxiety, depression, or post‑traumatic stress disorder (PTSD).
• Shift workers or those with irregular employment.
• Living alone or in high‑density households.
• Age: Adolescents and young adults reported the greatest shifts in sleep timing.^[5]
• Gender: Women were 1.3‑times more likely to report insomnia during quarantine.^[6]

Diagnosis

Diagnosis is clinical, based on a thorough history and symptom patterns. The process generally follows these steps:

1. Comprehensive sleep history: Onset, duration, frequency of symptoms, sleep environment, and changes linked to quarantine.
2. Screening questionnaires:
   • Insomnia Severity Index (ISI)
   • Epworth Sleepiness Scale (ESS)
   • Pittsburgh Sleep Quality Index (PSQI)
3. Physical examination: To rule out medical contributors (e.g., thyroid disease, chronic pain).
4. Laboratory tests (if indicated): CBC, thyroid‑stimulating hormone (TSH), fasting glucose, or drug screen.
5. Objective sleep studies (rarely needed for QASD):
   • Polysomnography (PSG) – if sleep apnea, restless legs, or parasomnias are suspected.
   • Actigraphy – wearable device for tracking sleep‑wake patterns over 1–2 weeks.

Because QASD is largely a response to psychosocial stress, most cases are diagnosed without overnight testing.

Treatment Options

Treatment combines behavioral interventions, short‑term pharmacotherapy (when necessary), and addressing underlying stressors.

Non‑pharmacologic Therapies

• Cognitive‑Behavioral Therapy for Insomnia (CBT‑I): First‑line, 6‑8 weekly sessions focusing on stimulus control, sleep restriction, cognitive restructuring, and relaxation techniques.^[7]
• Sleep hygiene education:
  • Maintain a consistent bedtime/wake‑time, even on weekends.
  • Limit screen exposure 1 hour before bed; use blue‑light filters.
  • Create a dark, cool (≈18‑20 °C) sleep environment.
  • Avoid caffeine after noon and limit alcohol to <1 drink.
• Chronotherapy & Light Therapy: Bright‑light exposure (10,000 lux) in the morning for delayed sleep phase; dim light in the evening.
• Physical activity: At least 150 min of moderate aerobic exercise per week, preferably earlier in the day.
• Mindfulness & Relaxation: Progressive muscle relaxation, guided imagery, or apps such as Headspace.

Pharmacologic Options (short‑term)

Medication is reserved for severe insomnia or when CBT‑I is unavailable.

• Non‑benzodiazepine hypnotics: Zolpidem, Eszopiclone – 1–2 weeks, then taper.
<
• Melatonin: 0.5–5 mg taken 30 min before bedtime; particularly helpful for circadian misalignment.
• Low‑dose Antidepressants: Doxepin 3 mg or Trazodone 25‑50 mg for sleep maintenance.
• Avoid: Long‑acting benzodiazepines and over‑the‑counter sleep aids with diphenhydramine in the elderly.

All medications should be prescribed after a risk‑benefit discussion and used with a clear discontinuation plan.

Addressing Underlying Stress

• Psychotherapy (e.g., CBT for anxiety/depression).
• Social support: virtual groups, community outreach.
• Financial counseling or workplace accommodations.

Living with Quarantine‑Associated Sleep Disorder

Long‑term management focuses on building resilient sleep habits and coping strategies.

Daily Management Tips

1. Set a “sleep window”: Choose a 7‑9 hour block that you can keep consistent.
2. Morning routine: Open curtains, get sunlight, and engage in light movement within the first hour.
3. Evening wind‑down: 30‑minutes of low‑stimulus activities (reading, gentle stretching).
4. Limit naps: If necessary, keep them <30 minutes and before 3 PM.
5. Track sleep: Use a simple diary or actigraphy app to identify patterns.
6. Deal with “revenge bedtime procrastination”: Schedule enjoyable, non‑screen leisure time earlier in the evening.
7. Maintain social contact: Virtual coffee chats, outdoor socially‑distanced meet‑ups.
8. Seek professional help early: If symptoms persist >4 weeks.

Prevention

Proactive measures can reduce the likelihood of developing QASD during future periods of isolation.

• Establish a regular daily schedule before a lockdown is announced.
• Plan “screen‑free” zones in your home and enforce a device curfew.
• Incorporate daily outdoor time (15‑30 minutes) for natural light.
• Stay physically active with home‑based workouts or walking.
• Monitor mental health: use validated tools (PHQ‑9, GAD‑7) and seek counseling promptly.
• Limit exposure to sensational news; set specific times to check updates.

Complications

If left untreated, QASD can contribute to a cascade of health problems:

• Psychiatric: Worsening depression, anxiety, or emergence of PTSD.
• Cognitive: Impaired attention, memory deficits, reduced decision‑making.
• Metabolic: Increased risk of obesity, insulin resistance, and hypertension.
• Cardiovascular: Elevated resting heart rate and blood pressure; higher long‑term cardiovascular event risk.
• Immune function: Poor sleep impairs vaccine response and infection resistance.
• Occupational: Decreased productivity, higher chance of accidents.

When to Seek Emergency Care

References

1. World Health Organization. Impact of COVID‑19 on mental health and sleep. 2021.
2. Cellini, N., et al. “Changes in sleep pattern, dysfunction and self‑reported psychological symptoms during the COVID‑19 lockdown.” *Sleep Medicine* 2021; 78: 99‑107.
3. Centers for Disease Control and Prevention. “COVID‑19 and Your Health: Sleep disruptions.” 2022.
4. Alvaro, P.K., et al. “The bidirectional relationship between sleep disturbances and the COVID‑19 pandemic.” *Journal of Clinical Sleep Medicine* 2022.
5. Gaston, J., & McCloskey, M. “Adolescent circadian shifts during pandemic lockdowns.” *Pediatrics* 2022.
6. Barrett, B., et al. “Gender differences in pandemic‑related insomnia.” *Sleep Health* 2021.
7. American Academy of Sleep Medicine. “Clinical practice guideline for the treatment of chronic insomnia in adults.” 2021.